Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Ovarian Neoplasms 27Breast Neoplasms 27Lung Neoplasms 26Carcinoma, Ovarian Epithelial 20Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Head and Neck Neoplasms 13Brenner Tumor 11Uterine Cervical Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Urinary Bladder Neoplasms 9Esophageal Neoplasms 9Stomach Neoplasms 8Endometrial Neoplasms 8Urethral Neoplasms 7Adenocarcinoma, Bronchiolo-Alveolar 6Sarcoma 5Prostatic Neoplasms 5Adenocarcinoma Of Esophagus 5Neurotoxicity Syndromes 4Neoplasm Metastasis 4Testicular Neoplasms 3Salivary Gland Neoplasms 3Radiation Injuries 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms, Male 3Thymoma 2Testicular Germ Cell Tumor 2Small Cell Lung Carcinoma 2

Interventions

Talc 1Radiotherapy, Conformal 1Pleurodesis 1Paclitaxel 1Fluorodeoxyglucose F18 1Doxycycline 1Cisplatin 1Carboplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pleural Effusion, Malignant × Paclitaxel × Clear all
NCT00993655 2023-08-28

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Canadian Cancer Trials Group

Phase 2 Completed
275 enrolled 13 charts
GynecologicThoracic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡